Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON (JNJ)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/17/2018 09/18/2018 09/19/2018 09/20/2018 09/21/2018 Date
139.96(c) 140.54(c) 140.46(c) 141.98(c) 142.88(c) Last
5 295 517 4 581 234 5 049 937 5 019 257 13 283 427 Volume
+0.34% +0.41% -0.06% +1.08% +0.63% Change
More quotes
Financials (USD)
Sales 2018 81 257 M
EBIT 2018 24 952 M
Net income 2018 16 036 M
Debt 2018 11 280 M
Yield 2018 2,50%
Sales 2019 83 185 M
EBIT 2019 26 638 M
Net income 2019 18 804 M
Debt 2019 587 M
Yield 2019 2,65%
P/E ratio 2018 21,10
P/E ratio 2019 18,25
EV / Sales2018 4,86x
EV / Sales2019 4,62x
Capitalization 383 B
More Financials
Company
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field.It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices.The Consumer segment includes products used in the baby care,... 
Sector
Pharmaceuticals
Calendar
09/24Presentation
More about the company
Surperformance© ratings of Johnson & Johnson
Trading Rating : Investor Rating :
More Ratings
Latest news on JOHNSON & JOHNSON
09/22HIGH SCHOOL FOOTBALL : West Rowan-Concord box
AQ
09/22J&J UNIT : Esketamine Study Didn't Show Statistical Significance for Primary End..
DJ
09/22JOHNSON & JOHNSON : 'Healthy Babies Are Worth the Wait' program to be held on We..
AQ
09/22JOHNSON & JOHNSON : Janssen Announces Results of Esketamine Nasal Spray Phase 3 ..
PU
09/21JOHNSON & JOHNSON : J&J Unit Agrees To Sell Sterilization Unit for $2.7 Billion
DJ
09/21JOHNSON & JOHNSON : to Host Investor Conference Call on Third-Quarter Results
AQ
09/21JOHNSON & JOHNSON : Janssen Submits New Drug Application to U.S. FDA Seeking App..
AQ
09/21JOHNSON & JOHNSON : Vision Showcases Latest Clinical Data and Eye Care Solutions..
PU
09/21Janssen launches first long-acting treatment for schizophrenia
AQ
09/21Janssen launches first long-acting treatment for schizophrenia
AQ
More news
Sector news : Pharmaceuticals - NEC
08:30aASTRAZENECA : Mixed Results from Farxiga Trial
DJ
08:16aSHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
03:05aAs China builds biotech sector, cash floods U.S. startups
RE
09/23ASTRAZENECA CEO WARNS OF MEDICINE SH : Sunday Times
RE
09/21EMA Nod to Eli Lilly Drug Stokes Competition in Migraine Prevention Market
DJ
More sector news : Pharmaceuticals - NEC
MarketScreener Strategies on JOHNSON & JOHNSON 
JOHNSON & JOHNSON - 2017
The underlying trend is to the upside
BUY
JOHNSON & JOHNSON - 2017
Expect the comeback of a strong trend
BUY
More Strategies
Qtime:1
News from SeekingAlpha
09/23The 3 Essential Investing Lessons Of The Financial Crisis 
09/22STOCKS TO WATCH : Calling Up Animal Spirits 
09/21Sutro Biopharma Prepares Terms For $75 Million U.S. IPO 
09/21THERE IS A MORE IMPORTANT QUESTION T : Johnson & Johnson 
09/21Buy This Stock If You Are Afraid Of An Imminent Bear Market 
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 144 $
Spread / Average Target 0,43%
EPS Revisions
Managers
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Charles O. Prince Independent Director
William David Perez Independent Director
Anne M. Mulcahy Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON2.26%383 312
PFIZER21.65%258 285
NOVARTIS-0.63%216 108
ROCHE HOLDING LTD.-4.60%211 501
MERCK AND COMPANY26.36%189 092
AMGEN17.94%132 756